Business Wire•October 1, 2020 United Health Pr
Post# of 476
United Health Products, Inc. (OTCPK: UEEC, "UHP" today announced that it has submitted documents requested by the FDA in conjunction with its PMA (Class III) application to use HemoStyp in internal surgeries. The company expects the FDA to grant approval to its PMA (Class III) application or request additional information within 30 days.
All details and updates regarding the Human Trials are now available to the public at:
https://www.clinicaltrials.gov/ct2/show/NCT03...amp;rank=1